Melarsoprol
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Also known as: arsobal, melarsaprol, melarsen B
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Melarsoprol is a drug catalogued in DrugCentral. Recorded indications include African trypanosomiasis.
- Indications: African trypanosomiasis.
- ATC code: P01CD01 (Arsenic compounds).
- Molecular formula: C12H15AsN6OS2; molecular weight 398.33 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- African trypanosomiasis
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
P01CD01 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS › Arsenic compounds |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Melarsoprol is on its molecule page.
| Molecular formula | C12H15AsN6OS2 |
|---|---|
| Molecular weight | 398.33 g/mol |
| CAS number | 494-79-1 |
| InChIKey | JCYZMTMYPZHVBF-UHFFFAOYSA-N |
| PubChem CID | 10311 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Melarsoprol used for?
DrugCentral lists the following indications for Melarsoprol: African trypanosomiasis.
What is the chemical formula of Melarsoprol?
Melarsoprol has the molecular formula C12H15AsN6OS2 and a molecular weight of 398.33 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3336 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL166 — compound record and bioactivity
- PubChem CID 10311 — chemical identifiers
- DrugBank DB12864 — drug record
- FDA UNII ZF3786Q2E8 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.